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The advent of new culture techniques resulting in more
than 60% of embryos developing in vitro to the blastocyst
stage suggests that blastocyst transfer in humans with its
potential to increase in-vitro fertilization success rates could
be a feasible option. Blastocyst quality markers, however,
are required to ensure that an increase in numbers is not
achieved at the expense of lowering quality. We have
previously reported a morphology based method for grad-
ing blastocysts. The current study sought to determine
whether the secretion of pregnancy-specific fJ-1-glycopro-
tein (SP1) (a trophoblast product known to be associated
with fetal well-being) by blastocysts of differing quality was
reflected in the morphological grading. SP1 concentrations
were measured in the culture medium of grade 1 (n = 19),
grade 2 (n = 4) and grade 3 (n = 4) blastocysts as well as
vacuolated morulae (n = 6) daily from day 1 to day 14.
Cumulative SP1 concentrations secreted by blastocysts
were significantly higher than those secreted by vacuolated
morulae. However, SP1 levels could not distinguish between
blastocysts of differing morphological grades. The incon-
sistent pattern of secretion suggests that at this early stage
of development, SP1 secretion is probably not sufficiently
defined to allow any differences in levels to be reflected by
the morphological grading.
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Introduction
After more than two 2 decades of research, the in-vitro
fertilization (IVF) live birth rate is still only 13.2% (Human
Fertilisation and Embryology Authority of UK, Annual Report,
1994). One possible reason for the low success could be the
transfer of four to eight cell embryos to an asynchronous
uterine environment on day 2 or 3 after insemination. Blastocyst
transfer is routinely practised in several domestic species e.g.
cattle, giving pregnancy rates of 40-60% (Iritani, 1988). This
suggests the beneficial effect of synchronizing the stage of
embryo development with that of the uterine endometrium.
In humans, although initial studies by Bolton et al. in 1991
showed a low success rate with the transfer of blastocysts
grown in conventional culture media, subsequently a number
of studies have shown blastocyst transfer to yield success rates
as high as 50%. Success was particularly observed in patients
who had repeated failed FVF attempts (Menezo et al, 1992;
Schillaci et al, 1994; Ciriminna et al, 1995). Besides, co-
culture techniques have resulted in an increase in the percentage
of embryos progressing to the blastocyst stage. Although the
value of co-culture has been contested by Van Blerkom in
1993, a number of groups have reported on blastocyst formation
rates >60% with improved culture techniques (M6nezo et al,
1990; Bongso et al., 1994; Ciriminna et al, 1995). Safeguards
are, however, required to ensure that an increase in blastocyst
numbers does not take place at the cost of lowering blastocyst
quality. This highlights the need to develop reliable methods
of assessing the quality of blastocysts developed under varying
culture conditions. Good quality blastocysts could then be
selected for transfer.
We have previously developed a system for separating
blastocysts of differing quality into three grades based on their
morphological appearance (Dokras et al., 1993). Morphological
grading is an attractive prospect as it is non-invasive and
easily performed. These rules for grading, however, have been
derived from experience and are subjective. Some objective
validation of the grading scheme and its ability to capture
blastocyst quality has been provided by studies which show
that it is related to human chorionic gonadotrophin (HCG)
secretion and nuclei counts (Dokras et al, 1993). Hardy
et al. (1989) have also shown that morphologically abnormal
blastocysts have significantly lower nuclei counts than their
normal counterparts. However, an investigation of other indic-
ators of blastocyst quality is required to ensure that the
morphological grading captures the overall wellbeing and
functional capacity of the blastocyst and not just die cell
number or the capacity to secrete HCG.
Pregnancy-specific P-l glycoprotein (SP1), like HCG, is
secreted by the trophoblast, and is detectable in die serum of
pregnant women as early as day 7 after the luteinizing hormone
peak (Grudzinskas et al, 1977). Its levels are associated
with feto-placental wellbeing and are predictive of pregnancy
outcome (Ahmed and Klopper, 1984). The exact role of SP1
remains unknown, but an immunosuppressive role in protecting
the fetus from rejection by the maternal immune system has
been postulated (Bischof, 1984).
Secretion of SP1 by cultured human embryos as early as
day 3 has been reported by Dimitriadou et al (1992). In
contrast, HCG secretion has not been detected before day 6
and in most embryos only after day 7 (Dokras et al, 1991).
This observation, as well as the likelihood that HCG and
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SPl secretion by the embryo have different biochemical
and physiological regulation (Bischof, 1984), suggests that
assessment of SPl may yield information relating to aspects
of embryo development that are independent from HCG
secretion. Given the biological significance of SPl, this study
sought to measure concentrations of SPl present in the embryo
culture fluid and determine whether the morphological grading
reflects the differences (if any) in concentrations of SPl
secreted by blastocysts of differing quality.
Materials and methods
Patients
The embryos used for research were spare embryos donated by
couples attending the FVF unit at the John Radcliffe Hospital, Oxford.
The couples gave informed consent and the project was approved by
the Central Oxford Research Ethics Committee (COREC) and the
Human Fertilisation and Embryology Authority (HFEA).
FVF procedure
Details of the IVF ovulation induction regime, oocyte retrieval and
embryo culture before transfer were as previously described (Dokras
et al., 1990). On day 2 each embryo was assessed based on its
morphological appearance, cleavage rate and characteristics of the
related oocyte and follicle. The three embryos assessed as being the
best were selected for transfer. Embryos not so selected were assigned
for research purposes on the same day.
Embryo culture
This study was restricted to the culture of bipronucleate spare
embryos. Once assigned for research, these embryos were transferred
to individual wells of 24-well Nunclon plates (Nunc, Delta, Denmark)
each of which contained 1 ml of Tyrode's 6 (T6) medium (Quinn
et al, 1985) supplemented with 10% heat-inactivated maternal
serum. In cases where insufficient maternal serum was available, T6
supplemented with 10% pooled serum (from women whose FVF
treatment resulted in successful pregnancies) was used. Every 24 h
the embryos were assessed morphologically, before being transferred
to a new well containing 1 ml of fresh equilibrated medium. The
culture medium from the previous well was stored at -20°C. If an
embryo became attached to the culture dish, the medium was carefully
removed and replaced with fresh equilibrated medium without dis-
lodging the embryo. Medium collected from embryos when allotted
for research on day 2 contained factors secreted by the embryo over
the previous 24 h and was therefore referred to as day 1 embryo
culture fluid. Similarly, medium collected on day 3 of culture is
designated day 2 embryo culture fluid and so on.
Morphological assessment and classification
Embryos were morphologically assessed using a Wilovert inverted
phase contrast microscope (Leica, Milton Keynes, UK). All embryos
were assessed daily up to day 8, after which only those embryos that
had formed blastocysts or were vacuolated at the morula stage were
cultured up to day 14. Details on the percentage of embryos
progressing to various stages of development on in-vitro culture under
the conditions described here can be found in Dokras et al. (1991).
At the blastocyst stage, embryos were graded based on their morpho-
logical appearance essentially after Dokras et al. (1993). Briefly,
grade 1 (BG1) were blastocysts characterized by an initially eccentric
cavity progressing to a well expanded cavity lined by a distinct inner
cell mass (ICM) region and trophectoderm layer. Grade 2 (BG2)
blastocysts were similar in appearance to BG1 but were preceded by
a transitional phase showing single or multiple vacuoles with sharp
borders at the morula stage. Grade 3 (BG3) were blastocysts with or
without initial vacuolation which showed several degenerative foci
in the ICM on the day of formation and an incompletely expanded
cavity. On observation of their developmental potential, hatching was
observed in 10 out of 19 BG1 (of these, three hatched partially), one
out of four BG2 and only one out of nine BG3. Also included in the
study were vacuolaled morulae (VM). These were embryos which
showed the presence of one or more small vacuoles at the morula
stage which could occasionally be mistaken for early cavitation. On
further monitoring up to day 14, these six morulae did not form
blastocysts and the zona remained intact They were, however,
included in the study in order to determine the SPl secretory capacity
of such 'poor quality embryos' as compared to that of blastocysts.
EUSA
A highly sensitive (10 pg/ml) double-antibody microplate enzyme-
linked immunosorbent assay (ELISA) was used to measure SPl in
the embryo culture fluid. High binding capacity 96-well plates
(Maxisorp, Nunc, Denmark) were coated the day before assay with
excess rabbit polyclonal anti-SPl IgG (Dako-immunoglobulins a/s,
Denmark) 25-40 pg/ml, in sodium carbonate, 0.05 M, pH 9.6,
75 ul/well. The coating solution was left overnight at 4°C and
aspirated next morning. Excess sites were then blocked with 200 ul
of bovine serum albumin (BSA), 5 mg/ml in phosphate buffered
saline (PBS), pH 7.4, for 2 h at room temperature. Plates were then
washed four times with PBS containing Tween-20 (0.1% v/v, PBST).
High protein carrier buffer (BSA, 20 mg/ml, and Emulsit, a non-
ionic detergent, 0.05% in PBS) was added to the culture medium
aliquot (1:3) and the sample was then added to microplate wells in
duplicate (75 ul/well). After initial incubation at 37°C for 60 min,
the plate was left overnight at 4°C. Next morning, the wells were
washed three times with PBST. The enzyme conjugate, horseradish
peroxidase coupled to anti-SPl IgG (Behringwerke, Germany), was
diluted 1:100 with the above high protein buffer before use. Incubation
was for 60 min at 37°C after which the wells were washed four times
with PBST and finally with peroxide-free Tween. The reaction was
developed with 100 |il sodium perborate (0.03%) as the substrate and
ortho-phenylene diamine in citrate-phosphate buffer, 0.1 M, pH 5.0
(1 mg/ml) as the chromogen, for 30 min at room temperature in the
dark. The reaction was stopped with 100 ul sulphuric acid, 2 M, the
plates shaken for 1 min, and the absorption measured in a Labsystems
(Finland) microplate ELISA reader at 492 nm. Lyophilized aliquots
made from pooled late pregnancy serum, diluted in normal male
serum calibrated against the World Health Organization (WHO)
reference preparation 78/610, were used as assay standards. The
detection limit of the test was 10 pg/ml.
Statistical analysis
The Mann-Whitney test was used to test for differences in SPl
secretion between the blastocysts and vacuolated morulae as well as
the hatched and intact blastocysts. The Kruskal-Wallis test was used
to test for differences in SPl secretion between the three grades of
blastocysts. In order to determine the cumulative secretion for each
embryo, the area under the curve obtained by joining points showing
the concentrations of secretion for each day was calculated (Matthews
et al, 1990). For ease of interpretation, comparison of the cumulative
concentrations of SPl secretion by the different groups has been
shown here using notched box plots. The dotted line in the plots
indicates the median while the notches approximate a 95% confidence
region around the median. The notched boxes contain 50% of the
data, 25% above and 25% below the median. Overlap of the notches
indicates the absence of a significant difference between the medians.
1039
RJLSalth etcd.
60
3 40
c
o
§
CO
20
1 2 3 4 5 7 B 9 10 11 12 13 14
Day of culture
Figure 1. Mean daily pregnancy-specific p"-l glycoprotcin (SP1)
secretion by 32 blastocysts (-•-) and six vacuolated morulae (-A-)
from day 1 to day 14 of culture.
Results
SP1 secretion by 32 blastocysts and six vacuolated morulae
was measured daily from day 1 to day 14. Concentrations of
SP1 secreted by each embryo over each day were obtained by
subtracting the levels detected in the respective culture medium
control from the levels detected in the embryo culture fluid.
Of the blastocysts, SP1 secretion was detected in 17/19 BG1,
4/4 BG2 and 6/9 BG3; 4/6 VM secreted SP1. The mean daily
SP1 secretion for all blastocysts and VM is shown in Figure
1. The earliest detection of SP1 (i.e. concentrations >10 pg/
ml) was on day 1 in eight out of the 38 embryos. Of these,
two were BG1, two BG2, one BG3 and three VM. No
individual embryo secreted SP1 over all 14 days of culture
and the maximum number of days over which SP1 was
detected was 10 for one BG1. Five blastocysts and one VM
showed detectable secretion over 1 day only. Five out of the
38 embryos continued to secrete SP1 on day 14. Of these,
three were BG1 and one each of BG2 and BG3.
The 32 blastocysts showed significantly higher {P = 0.02)
cumulative SP1 secretion as compared to the six vacuolated
morulae (Figures 2a and b). All three grades of blastocysts
also showed a consistent peak in the mean concentration of
secretion on day 3 which was absent in the vacuolated morulae
(Table I; Figure 1). BG1 and BG2 show a trend towards higher
daily cumulative SP1 concentrations than BG3 (Figure 3a).
On statistical analysis, however, the three grades of blastocysts
showed no significant difference in either the daily or cum-
ulative SP1 concentrations for the three grades (Figure 3b).
When the 12 blastocysts which hatched were compared with
those that remained intact within the zona, there was no
significant difference in the cumulative secretion (Figure 4).
For individual embryos, there was no relation between the SP1
secretion and the morphology and development of the embryo.
Discussion
SP1 concentrations secreted by embryos, classified on the
basis of their morphology, were measured to determine whether
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Figure 2. a Mean cumulative SP1 concentrations of 32 blastocysts
(-•-) and six vacuolated morulae (-A-) from day 1 to day 14 of
culture, b Statistical comparison of cumulative SP1 secretion by 32
human blastocysts and six vacuolated morulae over 14 days of
culture. For explanation of notched box plots, see statistical
analysis section. BG1, BG2, BG3 represent decreasing quality
grades of blastocysts; Vm = vacuolated morulae.
Table
SEM)
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
I. Daily
in pg/m
BG1
5.93 :
pregnancy-specific ($-1 glycoprotein (SP1) secretion (mean ±
lof BG1
t 3.25
21 ± 10.61
38.50 :
6.59 :
7.72 :
8.68 :
22.58 :
13.44 :
22.11 2
25.16 :
40.44 :
45.22 :
36.18 :
33.35 :
t 21.76
t 3.28
t 3.80
t4.87
t 7.67
t 6.58
t9.83
t 8.38
t 16.46
t 21.87
t 21.10
t 23.40
BG2, BG3 and VM from day 1 to
BG2
4.26 :
45.67 :
71.50 :
5.25 2
0.00 2
58.00 2
7.25 2
0.00 2
7.25 2
81.50 2
58.00 2
4X00 2
7.50 2
7.75 2
t 4.25
t 45.67
t 60.70
t 5.25
t 0.00
t 58.00
t 7.25
t 0.00
t 7.25
t 72.78
t 58.00
t 42.00
t 7.50
t 7.75
BG3
7.56 ± 6.40
19.22 ±11.66
23.44 :
3.89 :
9.88 :
6.44 :
2.00 :
2.22 :
2.00:
13.89 :
2.11 2
10.88 :
13.00 :
t 16.26
t 3.89
t 6.55
t 6.44
t 2.00
t 2.22
t 2.00
t 8.35
t 2.11
t 7.17
t 13.00
7.75 ± 7.75
day 14
VM
8.80 ± 5.43
1.67 ± 1.67
2.83 ± 2.83
0.00 ± 0.00
0.00 ± 0.00
1.67 ± 1.67
5.83 ± 4.17
0.00 ± 0.00
0.00 ± 0.00
4.00 ± 4.00
0.00 ± 0.00
3.83 ± 3.83
0.00 ± 0.00
0.00 ± 0.00
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Figure 3. a Mean cumulative SPl concentrations of 19 BG1 (-•-),
four BG2 (-A-) and nine BG3 (-•-) from day 1 to day 14 of
culture, b Statistical comparison of cumulative SPl secretion by 19
BG1, four BG2 and nine BG3 over 14 days of culture. For
explanation of notched box plots, see statistical analysis section.
See Figure 2 for definition of BG1, BG2 and BG3.
this grading system reflects variability in secretion (if any)
between blastocysts of differing quality. SPl was chosen for
investigation since, later in pregnancy, serum SPl concentra-
tions can be used to distinguish between normal singleton
pregnancies and abnormal pregnancies such as recurrent spon-
taneous abortions, intrauterine growth retardation, ectopic
pregnancies, low birth weight and pre-term labour (Raman
and Pawashe, 1986; Sinosich et al, 1986; Johnson et al,
1993a,b; Zhang et al., 1993). Using a highly sensitive immuno-
assay, low concentrations of SPl were detected in the embryo
culture fluid, confirming earlier findings (Dimitriadou et al,
1992). While Dimitriadou et al. (1992), however, studied the
concentrations of SPl in embryo culture fluid from day 3
onwards, we found that SPl secretion in the embryo culture
fluid can be detected as early as day 1. SPl concentrations
secreted by the blastocysts were significantly higher than those
by the vacuolated morulae, suggesting that in general there is
an association between SPl and embryo quality. In addition
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Figure 4. Comparison of cumulative pregnancy-specific p"-l
glycoprotein (SPl) secretion by 12 hatched and 20 intact human
blastocysts over 14 days of culture. For explanation of notched box
plots, see statistical analysis section.
the blastocysts showed a pattern of secretion that differed from
the VM with all three grades showing a distinct peak of
secretion on day 3. This peak is of particular interest, as it
could have the potential to discriminate between embryos
destined to develop into blastocysts and those destined to form
12 vacuolated morulae. However, on analysis, neither the
concentration of SPl secretion on day 3 nor the cumulative
day 1 to day 3 concentrations showed a statistical difference.
Blastocysts of differing developmental potential, as indicated
by their ability or inability to hatch, could not be distinguished
by the concentrations of SPl secretion.
Although the better grade (as defined by morphology)
blastocysts BG1 and BG2 showed a trend towards higher daily
mean cumulative SPl concentrations than BG3, there was no
significant difference in the cumulative or daily SPl secretion
between the three grades of blastocysts. Despite the initial
promise shown by differences in SPl concentrations, between
embryos of differing quality (i.e. blastocysts versus vacuolated
morulae), the lack of a significant difference in SPl concentra-
tions secreted by blastocysts belonging to the three morpho-
logical grades suggests that the present grading system does not
capture the ability of blastocysts to secrete SPl. Alternatively, it
raises the possibility that at this early stage of development,
SPl secretion may not be sufficiently defined to be incorporated
and reflected in a morphological grading scheme. This is
demonstrated by the finding that SPl was neither secreted by
all blastocysts nor was it detected for individual blastocysts
on all days of culture. Furthermore, the day of starting secretion
was highly variable ranging from day 1 for six blastocysts to
as late as day 7 for three and days 8 and 9 for one each
respectively. Once secretion was detected, it did not necessarily
persist, and it stopped and restarted at irregular intervals.
The concentrations of SPl detected here were much lower
than those reported by Pope et al. (1984) for baboon embryos
and Dimitriadou et al. (1992) for human embryos. Possible
causes for this could be the assay used and sub-optimal culture
conditions. The highest concentration of SPl detected in our
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study was 391 pg/ml per day secreted by a grade 1 blastocyst
on day 3 of culture, in contrast to 4800 pg/ml per 3 days
reported by Dimitriadou et al. (1992). This large difference
could have been due to the difference in culture media (they
used Ham's F-10 supplemented with 7% maternal serum)
which can affect embryo quality and thus secretory capacity.
However, this is unlikely, as blastocysts of an obviously good
quality, as indicated by their hatching, showed concentrations
of SP1 secretion much lower than those reported by
Dimitriadou et al. (1992). Another explanation could be
that in our study the medium was changed daily, whereas
Dimitriadou et al. (1992) changed the medium only once in 3
days for most embryos. It is possible that frequent changes of
the culture medium could deplete embryo-derived factors
which stimulate SP1 secretion. Unfortunately no direct compar-
ison of SP1 concentrations in culture medium using the assay
system employed by Dimitriadou et al. (1992) is possible as
the Enzygnost SP1, Behringwerke kit used by them is no
longer commercially available. Likewise, the media which
they used to measure SP1 have also been utilized fully.
To conclude, differences in concentrations of SP1 secretion
by cultured embryos are not reflected in the morphological
grading. The absence of a pattern and inconsistent SP1 secre-
tion, however, suggest that differences in SP1 concentrations
secreted by blastocysts of differing quality are not defined
enough to allow incorporation into the grading scheme. Other
non-invasive markers of blastocyst quality therefore need to
be investigated and the information obtained utilized to improve
the grading scheme to allow it simultaneously to reflect
differences in a number of markers. This would strengthen the
case for using the grading scheme in practice for selecting
blastocysts for transfer as well as for assessing the effficacy
of blastocyst culture techniques. Such work is currently in
progress in this laboratory.
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